Mohali, Punjab
GST No. 03ACGPL2683J1ZK
Call 08048604906 92% Response Rate
Send Enquiry
Minimum Order Quantity: 200 Vial
Product Brochure
| Brand | CRITENSIVE CARE |
| Also gives | Third Party Manufacturing, PCD Pharma Franchise |
| Service Loacation | Mohali |
| Service Type | ONLINE/OFFLINE |
| Service Mode | ONLINE/OFFLINE |
| Payment Mode | Online/Offline |
View Complete details
Minimum Order Quantity: 1000 Vial
Product Brochure
| Strength | 1 gm |
| Brand Name | SALVACEF |
| Manufacturer | SALVUS PHARMA |
| Injection Site | IV only |
| Form | Solution |
| Packaging Type | Vial |
| Composition | Ceftriaxone 1000 Mg Injection |
| Country of Origin | Made in India |
Additional Information:
View Complete details
Minimum Order Quantity: 1000 Vial
Product Brochure
| Strength | 250 mg |
| Brand Name | SALVACEF |
| Manufacturer | SALVUS PHARMA |
| Injection Site | IV only |
| Form | Solution |
| Packaging Type | Vial |
| Composition | Ceftriaxone 250 Mg Injection |
| Country of Origin | Made in India |
Additional Information:
View Complete details
Minimum Order Quantity: 1000 Vial
Product Brochure
| Strength | 500 mg |
| Brand Name | salvacef |
| Manufacturer | salvus pharma |
| Injection Site | IV only |
| Form | Solution |
| Packaging Type | Vial |
| Composition | Ceftriaxone Injection 500mg |
| Country of Origin | Made in India |
Additional Information:
View Complete details
Minimum Order Quantity: 500 Vial
| Strength | 281.25 mg |
| Pack Type | Vial |
| Composition | Ceftriaxone 250mg + Tazobactam 31.25 mg |
| Brand Name | Salvacef-T 281.25 |
| Manufacturer | Salvus Pharma |
| Shelf Life | 24 Months |
Ceftriaxone tazobactam belongs to a class of medication called 'antibiotics' used to treat several bacterial infections of the urinary tract, blood, bones and joints, heart, brain, chest, ears, skin, or soft tissues.A bacterial infection is a condition in which harmful bacteria grow in the body and cause infection. It can infect any part of the body and multiply very quickly. Ceftriaxone+tazobactam does not work against infections caused by the virus.
Ceftriaxone+tazobactam is a combination of two drugs: Ceftriaxone (antibiotic) and Tazobactum (beta-lactamase inhibitor). Ceftriaxone belongs to the class of antibiotics that works by interfering with the formation of the bacterial cell wall (a protective covering) necessary for their survival. Thereby damaging the bacterial cell wall and killing bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.
You are advised to take Ceftriaxone+tazobactam for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience diarrhea, rash, or abnormalities with white blood cells and platelets. Most of these side effects of Ceftriaxone+tazobactam do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Ceftriaxone+tazobactam, penicillins, or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, please inform your doctor before taking Ceftriaxone+tazobactam. Drive only if you are alert as Ceftriaxone+tazobactam may cause dizziness.
You are recommended to complete the full course of Ceftriaxone+tazobactam as prescribed by your doctor for effective results. Ceftriaxone+tazobactam may interact with certain tests such as glucose (sugar) in urine and coomb’s test, giving unusual results. Therefore, inform the doctor that you are taking Ceftriaxone+tazobactam before undergoing any tests.
Diarrhoea
Rash
Raised white blood cells
Raised platelets
Nausea
Vomiting
Upset stomach
Blood clots
Dizziness
headache
a lump where the medicine was injected,
Sweating
Additional Information:
View Complete details
Minimum Order Quantity: 1000 Piece
Product Brochure
| Dose | 500 mg/ 2ml |
| Packaging Type | Vial |
| Form | Injection |
| Shelf life | 18 months |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
Additional Information:
View Complete details